Non-invasive Diagnosis of Pulmonary Embolism by Use of Biomarkers in Exhaled Breath

CompletedOBSERVATIONAL
Enrollment

88

Participants

Timeline

Start Date

January 11, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Pulmonary Embolism
Interventions
DIAGNOSTIC_TEST

New method for diagnosis of pulmonary embolism (PE) in order to validate/consolidate 151 putative identified biomarkers for PE in the exhaled breath.

The collection time will be an average of 7 minutes. As the patient breathes through a mouthpiece, the exhaled breath is lead through the collection device, and an indicative amount af the exhaled air is led into a clear plastic bag. When the plastic bag is fully inflated, it indicates that the minimum required amount of exhaled breath (approximately 30 liters) has passed through the filter.

Trial Locations (1)

Unknown

Aalborg University Hospital, Aalborg

All Listed Sponsors
collaborator

University of Aarhus

OTHER

lead

Aalborg University Hospital

OTHER

NCT06135220 - Non-invasive Diagnosis of Pulmonary Embolism by Use of Biomarkers in Exhaled Breath | Biotech Hunter | Biotech Hunter